Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Baxter
Fish and Richardson
Express Scripts
Julphar
Teva
Federal Trade Commission
Boehringer Ingelheim
AstraZeneca
McKesson

Generated: January 17, 2018

DrugPatentWatch Database Preview

TUZISTRA XR Drug Profile

« Back to Dashboard

Which patents cover Tuzistra Xr, and when can generic versions of Tuzistra Xr launch?

Tuzistra Xr is a drug marketed by Vernalis R And D Ltd and is included in one NDA. There are two patents protecting this drug.

This drug has twenty-one patent family members in fourteen countries.

The generic ingredient in TUZISTRA XR is chlorpheniramine polistirex; codeine polistirex. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine polistirex; codeine polistirex profile page.
Summary for TUZISTRA XR
Drug patent expirations by year for TUZISTRA XR
Pharmacology for TUZISTRA XR

US Patents and Regulatory Information for TUZISTRA XR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vernalis R And D Ltd TUZISTRA XR chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 207768-001 Apr 30, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Vernalis R And D Ltd TUZISTRA XR chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 207768-001 Apr 30, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for TUZISTRA XR

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,747,902 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
9,675,704 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
8,202,537 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
9,522,191 Modified release formulations containing drug--ion exchange resin complexes ➤ Subscribe
8,337,890 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
8,883,217 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
8,597,684 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
8,491,935 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
9,675,703 Modified release formulations containing drug - ion exchange resin complexes ➤ Subscribe
9,198,864 Modified release formulations containing drug-ion exchange resin complexes ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for TUZISTRA XR

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
AstraZeneca
US Army
McKinsey
Fuji
McKesson
Harvard Business School
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot